An analysis of NIV use among patients with spinal muscular atrophy and amyotrophic lateral sclerosis included in the RARAS project between 2018 and 2024
Background: Neuromuscular diseases, such as Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy, encompass a diverse group of conditions that affect the motor unit, resulting in muscle weakness, atrophy, and respiratory compromise. These diseases often present a progressive course, leading to significant challeng...